trending Market Intelligence /marketintelligence/en/news-insights/trending/79V_2HFpsbKK-cHWHNivgw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Rexahn Pharmaceuticals to raise $8M in registered direct offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Rexahn Pharmaceuticals to raise $8M in registered direct offering

Rexahn Pharmaceuticals, Inc. plans to raise about $8 million via a registered direct offering of 3.27 million shares at $2.45 apiece.

The shares will come bundled with a total of 1.63 million warrants to buy an additional stock at $2.85 apiece.

The offering is expected to close by Oct. 17 and will help raise funds for the continued development of the company's product pipeline, including RX-3117 and RX-5902.

H.C. Wainwright & Co. LLC is acting as the exclusive placement agent for the offering.